Chromosome-damaging action of isoniazid and thiacetazone on human lymphocyte cultures in vivo.
Antitubercular drugs in general are given in various combinations, one being isoniazid and thiacetazone. In the present study, was evaluated the in vivo chromosome-damaging effects of a combination of these two drugs in 72 h lymphocyte cultures. Chromosome aberrations were significantly increased in the patients treated with INH and thiacetazone as compared with two types of controls: (1) tuberculosis patients before starting the drug treatment and (2) individuals from the general population. The most frequently observed aberrations were chromatid breaks and gaps. It has been shown that individually, isoniazid may not be clastogenic on human chromosomes in therapeutic doses. The effects of thiacetazone on human chromosomes are not known. Consequently, the enhancement in chromosomal aberrations in the drug-exposed patients may be due to a synergistic effect of isoniazid and thiacetazone or to the clastogenic effects of thiacetazone alone.
D000293:Adolescent; D000328:Adult; D002478:Cells, Cultured; D002877:Chromosomes, Human / Q000187:drug effects*; D004338:Drug Combinations; D006801:Humans; D007538:Isoniazid / Q000009:adverse effects*; D008214:Lymphocytes / Q000187:drug effects*; D013828:Thioacetazone / Q000009:adverse effects*; D014376:Tuberculosis / Q000188:drug therapy
D004338:Drug Combinations; D013828:Thioacetazone; D007538:Isoniazid